Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pathogenicity, transmissibility, and fitness of SARS-CoV-2 Omicron in Syrian hamsters
Shuofeng Yuan, Zi‐Wei Ye, Ronghui Liang, et al.
Science (2022) Vol. 377, Iss. 6604, pp. 428-433
Closed Access | Times Cited: 166

Showing 26-50 of 166 citing articles:

Reduced airborne transmission of SARS-CoV-2 BA.1 Omicron virus in Syrian hamsters
Adrianus C. M. Boon, Tamarand L. Darling, Peter Halfmann, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 12, pp. e1010970-e1010970
Open Access | Times Cited: 28
Long-term effect of SARS-CoV-2 infection on cardiovascular outcomes and all-cause mortality
Aneta Aleksova, Alessandra Lucia Fluca, Giulia Gagno, et al.
Life Sciences (2022) Vol. 310, pp. 121018-121018
Open Access | Times Cited: 27
Key Considerations during the Transition from the Acute Phase of the COVID-19 Pandemic: A Narrative Review
Piotr Rzymski, Maria Pokorska‐Śpiewak, Teresa Jackowska, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1502-1502
Open Access | Times Cited: 19
Continued evasion of neutralizing antibody response by Omicron XBB.1.16
Julia N. Faraone, Panke Qu, Yi-Min Zheng, et al.
Cell Reports (2023) Vol. 42, Iss. 10, pp. 113193-113193
Open Access | Times Cited: 19
Syrian hamster convalescence from prototype SARS-CoV-2 confers measurable protection against the attenuated disease caused by the Omicron variant
Kathryn A. Ryan, Kevin R. Bewley, Robert J. Watson, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 4, pp. e1011293-e1011293
Open Access | Times Cited: 18
Epidemiological characteristics of the three waves of COVID-19 epidemic in Taiwan during April 2022 to March 2023
Yi‐Hsuan Chen, Yu-Neng Cheuh, Chiu‐Mei Chen, et al.
Journal of the Formosan Medical Association (2023) Vol. 122, Iss. 11, pp. 1174-1182
Open Access | Times Cited: 18
Antibodies targeting a quaternary site on SARS-CoV-2 spike glycoprotein prevent viral receptor engagement by conformational locking
Lihong Liu, Ryan G. Casner, Yicheng Guo, et al.
Immunity (2023) Vol. 56, Iss. 10, pp. 2442-2455.e8
Open Access | Times Cited: 16
SARS-CoV-2 variant of concern fitness and adaptation in primary human airway epithelia
Rita M. Meganck, Caitlin E. Edwards, Michael L. Mallory, et al.
Cell Reports (2024) Vol. 43, Iss. 4, pp. 114076-114076
Open Access | Times Cited: 6
In Silico Analyses Indicate a Lower Potency for Dimerization of TLR4/MD-2 as the Reason for the Lower Pathogenicity of Omicron Compared to Wild-Type Virus and Earlier SARS-CoV-2 Variants
Ralf Kircheis
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5451-5451
Open Access | Times Cited: 6
Frequency, kinetics and determinants of viable SARS-CoV-2 in bioaerosols from ambulatory COVID-19 patients infected with the Beta, Delta or Omicron variants
Shameem Z. Jaumdally, Michele Tomasicchio, Anil Pooran, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Animal models of Long Covid: A hit-and-run disease
Alexandra Schaefer, Sarah R. Leist, John M. Powers, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 773
Open Access | Times Cited: 5
Animal Models for Human-Pathogenic Coronavirus and Animal Coronavirus Research
Fenglian Xiao, Jincheng Hu, Minsheng Xu, et al.
Viruses (2025) Vol. 17, Iss. 1, pp. 100-100
Open Access
Natural infection of SARS-CoV-2 variant XBB.1.9.1.4.1 in laboratory Syrian hamsters
Chunmao Zhang, Zhendong Guo
Microbiology Spectrum (2025)
Open Access
Pathogenesis and transmission of SARS-CoV-2 D614G, Alpha, Gamma, Delta, and Omicron variants in golden hamsters
Andra Banete, Bryan D. Griffin, Juan Carlos Corredor, et al.
npj Viruses (2025) Vol. 3, Iss. 1
Open Access
NIEAs elicited by wild-type SARS-CoV-2 primary infection fail to enhance the infectivity of Omicron variants
Qi Gui, Haiyan Wang, Congcong Liu, et al.
Virology Journal (2025) Vol. 22, Iss. 1
Open Access
A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection
Juan Shi, Jian Zheng, Wanbo Tai, et al.
Journal of Virology (2022) Vol. 96, Iss. 17
Open Access | Times Cited: 23
Comparative analysis of SARS‐CoV‐2 Omicron BA.2.12.1 and BA.5.2 variants
Chon Phin Ong, Zi‐Wei Ye, Kaiming Tang, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Closed Access | Times Cited: 23
Loss-of-function mutation in Omicron variants reduces spike protein expression and attenuates SARS-CoV-2 infection
Michelle N. Vu, R. Elias Alvarado, Dorothea R. Morris, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 14
Comparative pathogenicity of BA.2.12, BA.5.2 and XBB.1 with the Delta variant in Syrian hamsters
Sreelekshmy Mohandas, Anita M. Shete, Abhimanyu Kumar, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 13
Challenges and Prospects in Developing Future SARS-CoV-2 Vaccines: Overcoming Original Antigenic Sin and Inducing Broadly Neutralizing Antibodies
John P. Evans, Shan‐Lu Liu
The Journal of Immunology (2023) Vol. 211, Iss. 10, pp. 1459-1467
Open Access | Times Cited: 13
The spread of the omicron variant: Identification of knowledge gaps, virus diffusion modelling, and future research needs
Uttpal Anand, Tarun Pal, Alessandra Zanoletti, et al.
Environmental Research (2023) Vol. 225, pp. 115612-115612
Open Access | Times Cited: 12
Neutralisation of SARS-CoV-2 by monoclonal antibody through dual targeting powder formulation
Han Cong Seow, Jian‐Piao Cai, Harry W. Pan, et al.
Journal of Controlled Release (2023) Vol. 358, pp. 128-141
Open Access | Times Cited: 12
Identification of the SARS-unique domain of SARS-CoV-2 as an antiviral target
Bo Qin, Ziheng Li, Kaiming Tang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 12
PMI-controlled mannose metabolism and glycosylation determines tissue tolerance and virus fitness
Ronghui Liang, Zi‐Wei Ye, Zhenzhi Qin, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Tailor-made molecular imprints for biological event intervention
Fan Ding, Yue Ma, Wensi Fan, et al.
Trends in biotechnology (2024) Vol. 42, Iss. 9, pp. 1097-1111
Closed Access | Times Cited: 4

Scroll to top